(HealthDay)—For adults with sickle cell disease (SCD) with uncomplicated vaso-occlusive crises, outcomes are significantly better with treatment at an infusion center (IC) compared with an
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
